| 11/16/2026 1:00 PM | BioAge Labs (1709941) Subject Cormorant Asset Management, LP (1583977) Filed by | Form SCHEDULE 13G/A | |
| 11/05/2026 3:35 PM | BioAge Labs (1709941) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/05/2026 3:40 PM | BioAge Labs (1709941) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2026 3:55 PM | BioAge Labs (1709941) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/05/2026 4:00 PM | BioAge Labs (1709941) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 06/30/2026 3:21 PM | Barton Shane (1836297) Reporting BioAge Labs (1709941) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/29/2026 3:35 PM | Barton Shane (1836297) Reporting BioAge Labs (1709941) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/12/2026 3:31 PM | BioAge Labs (1709941) Issuer Davidson Michael H. (1573785) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 3:33 PM | BioAge Labs (1709941) Issuer ENRIGHT PATRICK G (1253886) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 3:34 PM | BioAge Labs (1709941) Issuer HEALY JAMES (1245624) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 3:35 PM | BioAge Labs (1709941) Issuer Hemrajani Rekha (1771213) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BIOA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioAge Labs and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/12/2026 3:37 PM | BioAge Labs (1709941) Issuer Pande Vijay Satyanand (1840663) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 7:00 AM | BioAge Labs (1709941) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 3:15 PM | BioAge Labs (1709941) Subject Khosla Ventures VI, L.P. (1734961) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 12:18 PM | BioAge Labs (1709941) Subject Cormorant Asset Management, LP (1583977) Filed by | Form SCHEDULE 13G/A | |
| 05/08/2026 8:10 AM | BioAge Labs (1709941) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/08/2026 8:05 AM | BioAge Labs (1709941) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/24/2026 3:19 PM | BioAge Labs (1709941) Issuer GOLDSTEIN DOV A MD (1120478) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:25 PM | BioAge Labs (1709941) Filer | Form ARS | |
| 04/21/2026 3:05 PM | BioAge Labs (1709941) Filer | Form DEF 14A | |
| 04/21/2026 3:06 PM | BioAge Labs (1709941) Filer | Form DEFA14A | |
| 04/03/2026 3:07 PM | BioAge Labs (1709941) Issuer RUBIN PAUL D (1210905) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 9:53 AM | BioAge Labs (1709941) Subject RUBIN PAUL D (1210905) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/24/2026 3:22 PM | BioAge Labs (1709941) Filer | Form S-3ASR | |
| 03/24/2026 8:10 AM | BioAge Labs (1709941) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/24/2026 8:15 AM | BioAge Labs (1709941) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/02/2026 9:17 AM | BioAge Labs (1709941) Subject RUBIN PAUL D (1210905) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/19/2026 3:34 PM | Barton Shane (1836297) Reporting BioAge Labs (1709941) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 3:36 PM | BioAge Labs (1709941) Issuer Fortney Kristen (2032751) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 3:38 PM | BioAge Labs (1709941) Issuer GOLDSTEIN DOV A MD (1120478) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 3:40 PM | BioAge Labs (1709941) Issuer Morgen Eric (2036289) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 5:23 PM | ADAR1 Capital Management, LLC (1940272) Filed by BioAge Labs (1709941) Subject | Form SCHEDULE 13G/A | |
| 02/17/2026 2:02 PM | BioAge Labs (1709941) Subject Cormorant Asset Management, LP (1583977) Filed by | Form SCHEDULE 13G/A | |
| 02/03/2026 3:23 PM | BioAge Labs (1709941) Issuer GOLDSTEIN DOV A MD (1120478) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 8:43 AM | BioAge Labs (1709941) Subject RUBIN PAUL D (1210905) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/22/2026 3:32 PM | BioAge Labs (1709941) Filer | Form 424B5 | |
| 01/22/2026 3:34 PM | BioAge Labs (1709941) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/20/2026 3:01 PM | BioAge Labs (1709941) Filer | Form 424B5 | |
| 01/20/2026 8:05 AM | BioAge Labs (1709941) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/13/2026 3:36 PM | BioAge Labs (1709941) Subject Fortney Kristen (2032751) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/13/2026 3:16 PM | BioAge Labs (1709941) Subject GOLDSTEIN DOV A MD (1120478) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
CFA: Bank of America Said THIS (Ad) On January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level.
Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval.
But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing. Click here to watch how to become your own bank before the switch flips. |
| 01/12/2026 8:10 AM | BioAge Labs (1709941) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/02/2026 11:56 AM | BioAge Labs (1709941) Subject RUBIN PAUL D (1210905) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/11/2025 3:21 PM | BioAge Labs (1709941) Issuer RUBIN PAUL D (1210905) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 10:23 AM | BioAge Labs (1709941) Subject RUBIN PAUL D (1210905) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/05/2025 5:20 PM | BioAge Labs (1709941) Issuer RUBIN PAUL D (1210905) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/04/2025 3:30 PM | BioAge Labs (1709941) Subject RUBIN PAUL D (1210905) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/04/2025 8:05 AM | BioAge Labs (1709941) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |